Why are RECOVER's first round of Long COVID clinical trials failing?

The U.S.'s flagship Long COVID research program has received over a billion dollars in funding and had years of input from people with the disease. But its first round of clinical trials are failing, at least in the results out so far.In this episode of Still Here, producer Melanie Marich talks to co-host and Sick Times co-founder Betsy Ladyzhets about the initial results from the NIH’s RECOVER trials, and why those results have left many patients and advocates in the Long COVID community disappointed.Subscribe to Still Here wherever you get your podcasts, and leave us a review telling us what you think of this episode.